Neuron
Volume 75, Issue 5, 6 September 2012, Pages 824-837
Journal home page for Neuron

Article
JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides

https://doi.org/10.1016/j.neuron.2012.06.024Get rights and content
Under an Elsevier user license
open archive

Summary

Although Aβ peptides are causative agents in Alzheimer's disease (AD), the underlying mechanisms are still elusive. We report that Aβ42 induces a translational block by activating AMPK, thereby inhibiting the mTOR pathway. This translational block leads to widespread ER stress, which activates JNK3. JNK3 in turn phosphorylates APP at T668, thereby facilitating its endocytosis and subsequent processing. In support, pharmacologically blocking translation results in a significant increase in Aβ42 in a JNK3-dependent manner. Thus, JNK3 activation, which is increased in human AD cases and a familial AD (FAD) mouse model, is integral to perpetuating Aβ42 production. Concomitantly, deletion of JNK3 from FAD mice results in a dramatic reduction in Aβ42 levels and overall plaque loads and increased neuronal number and improved cognition. This reveals AD as a metabolic disease that is under tight control by JNK3.

Highlights

► JNK3 activation is integral to the development of AD pathology ► JNK3 regulates APP endocytosis ► Ab42 activates AMPK ► Ab42 inhibits the mTOR pathway

Cited by (0)